The gelatinous tissue of the umbilical cord, a rich source of young MSCs.
The gelatinous matrix surrounding umbilical-cord blood vessels—rich in stem and immune cells that clinics harvest at birth from discarded cords. It's abundant and non-invasive to collect, making it commercially attractive. Wharton's jelly cells show promise in inflammatory and autoimmune contexts because they naturally suppress immune overreaction. When comparing clinics, ask how they isolate and expand these cells: crude extracts differ vastly from purified, characterised populations. Also clarify whether their cord-derived cells are fresh or cryopreserved; freeze-thaw cycles degrade viability by 10–30%.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment